MoonRISe-1: TAR-210 for non-muscle-invasive bladder cancer
This Medudy course is a video tutorial for physicians on "MoonRISe-1: TAR-210 for non-muscle invasive bladder cancer". Despite the availability of treatment options for patients with intermediate-risk non-muscle-invasive bladder cancer, recurrence rates remain high. The Moonrise-1 trial is investigating TAR-210, an intravesical drug delivery system that enables the sustained release of erdafitinib directly into the bladder. [...]